Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Frink

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Scientific Reports|February 24, 2023
Predicting tracheostomy in multiple injured patients with severe thoracic injury (AIS ≥ 3) with the new T<sub>3</sub>P-Score: a multivariable regression prediction analysisFelix M Bläsius, Sebastian Wutzler, Philipp Störmann, et al.
The Journal of Clinical Investigation|January 24, 2002
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligationHans-Joachim Anders, Volker Vielhauer, Michael Frink, et al.
Journal of the American Society of Nephrology : JASN|May 22, 2004
Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) miceHans-Joachim Anders, Emilia Belemezova, Vaclav Eis, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Scientific Reports|February 24, 2023
Predicting tracheostomy in multiple injured patients with severe thoracic injury (AIS ≥ 3) with the new T<sub>3</sub>P-Score: a multivariable regression prediction analysisFelix M Bläsius, Sebastian Wutzler, Philipp Störmann, et al.
The Journal of Clinical Investigation|January 24, 2002
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligationHans-Joachim Anders, Volker Vielhauer, Michael Frink, et al.
Journal of the American Society of Nephrology : JASN|May 22, 2004
Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) miceHans-Joachim Anders, Emilia Belemezova, Vaclav Eis, et al.
Pageof 10